These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1349796)

  • 1. Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells.
    Yang LY; Trujillo JM; Su YZ
    Anticancer Res; 1992; 12(2):473-9. PubMed ID: 1349796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
    Yang LY; Trujillo JM
    Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML; Hoeltge GA; Dalton WS; Trent JM
    Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
    Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
    Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
    Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
    Nieuwint AW; Baas F; Wiegant J; Joenje H
    Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
    Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG
    Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
    Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
    Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.
    Slovak ML; Coccia M; Meltzer PS; Trent JM
    Anticancer Res; 1991; 11(1):423-8. PubMed ID: 1673331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
    Evans CH; Baker PD
    Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between multidrug resistance in human colon carcinoma LoVo/Adr cell line and intracellular calcium ion concentration].
    Ma Q; Zhang ZS; Zhang YL; Lai ZS
    Ai Zheng; 2002 Aug; 21(8):846-9. PubMed ID: 12478890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
    Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
    Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
    Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.